thymidine has been researched along with dasatinib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baumgartner, C; Bennett, KL; Esterbauer, H; Ferenc, V; Gleixner, KV; Gruze, A; Lee, FY; Peter, B; Pickl, WF; Remsing Rix, LL; Samorapoompichit, P; Sillaber, C; Superti-Furga, G; Valent, P | 1 |
1 other study(ies) available for thymidine and dasatinib
Article | Year |
---|---|
Dasatinib inhibits the growth and survival of neoplastic human eosinophils (EOL-1) through targeting of FIP1L1-PDGFRalpha.
Topics: Apoptosis; Cell Division; Cell Line, Tumor; Cell Survival; Dasatinib; DNA Replication; Eosinophils; Flow Cytometry; Humans; Hypereosinophilic Syndrome; mRNA Cleavage and Polyadenylation Factors; Protein Kinase Inhibitors; Pyrimidines; Sequence Deletion; Thiazoles; Thymidine | 2008 |